RT Journal Article
SR Electronic
T1 Oxygen transfer characteristics of a hollow fiber dialyser: toward possible repurposing of dialysers as blood oxygenators in the context of constrained availability of respiratory support
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.06.20055236
DO 10.1101/2020.04.06.20055236
A1 Rubin, David M.
A1 Stacey, Neil T.
A1 Matambo, Tonderayi
A1 Hildebrandt, Diane
YR 2020
UL http://medrxiv.org/content/early/2020/04/11/2020.04.06.20055236.abstract
AB The mass transfer characteristics for oxygen from the gas phase to blood in a hollow fiber renal dialysis unit was investigated in vitro with a view to using such devices to effect respiratory support in patients with viral pneumonia and acute respiratory distress syndrome. In our in vitro experiments, which were severely curtailed by prevailing circumstances, we used water as a substitute on the blood side. The water was saturated rapidly indicating that the system was flow limited rather than diffusion limited for oxygen transfer. Using these findings, we estimated the expected performance with blood and the results suggest that two dialysis units operating in parallel with a pure oxygen gas supply running counter-current to the blood flow, could supply up to 40% of the total required oxygen demand rate in an adult patient. While not studied, carbon dioxide elimination is likely to be feasible as well. It is thus possible that hollow fiber dialysis units operating with suitable roller pumps in a veno-venous access configuration, could serve as a cost-effective and readily available alternative or adjunct for respiratory support in the face of severe resource constraints. Verification and extension of our study is needed by well resourced laboratories who are still able to function during this unprecedented period of restrictions. If, after further studies and clinical considerations, this approach appears feasible, then consideration may be given to clinical deployment of this technique in desperate situations where no alternative exists to preserve life.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo significant costs. Used the laboratory facilities of the relevant institutions.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data is included in the manuscript.